|
Prevalence of chronic kidney disease (CKD) in population-based studies from Europe |
|||||||
| Prevalence of CKD |
|||||||
|
|
|||||||
| Author [ref.] year |
Country |
Study population, study design, number of participants, response, age, gender |
MDRD equation |
CG/BSA equation |
|||
|
|
|
|
|
|
|||
| Brugts et al. [28] 2005 |
Netherlands |
Participants of the Rotterdam Study, prospective cohort study, N = 4484, response 78%, aged ≥ 55 yrs. (mean age: 69.6 yrs.), 36.3% males. |
NR |
Overall: 44.9% |
|||
|
|
|
|
|
|
|||
| Cirillo et al. [29] 2006 |
Italy |
Participants from central Italy, cross-sectional study, N = 4574, response NR, aged 18–95 yrs., 45.5% males. |
Overall: 6.4% Men: 6.5%, Women: 6.2% |
NR |
|||
| Age (yrs.) |
Men |
Women |
|||||
| 18–44 |
0.6% |
1.3% |
|||||
| 45–54 |
2.6% |
1.3% |
|||||
| 55–64 |
7.3% |
5.4% |
|||||
| 65–74 |
15.0% |
11.0% |
|||||
| 75+ |
34.5% |
31.6% |
|||||
|
|
|
|
|
|
|||
| Hallan et al. [30] 2006 |
Norway |
Participants of the second Health Survey of Nord-Trondelag County (HUNT II), cross-sectional study, N = 65181, response 70.4%, aged ≥ 20 yrs. (mean age: 50.2 yrs.), 46.8% men. |
Overall: 4.7% Men: 3.6%, Women: 5.7% |
NR |
|||
| Age (yrs.) |
|||||||
| 20–39 |
0.2% |
||||||
| 30–59 |
1.4% |
||||||
| 60–69 |
6.3% |
||||||
| 70+ |
18.6% |
||||||
|
|
|
|
|
|
|||
| Nitsch et al. [31] 2006 |
Switzerland |
Participants of the Swiss SAPALDIA Study, random sample, cross-sectional study, N = 6317, response NR, aged ≥ 18 yrs., 49% males. |
Overall: 8.1% Men: 4.5%, Women: 11.5% |
NR |
|||
| Age (yrs.) |
Men |
Women |
|||||
| < 55 |
1.1% |
7.9% |
|||||
| 55–65 |
7.1% |
23.5% |
|||||
| 66+ |
12.9% |
35.9% |
|||||
|
|
|
|
|
|
|||
| Otero et al. [32] 2005 |
Spain |
Randomly selected participants of the Estudio Epidemioloógic o de la Insuficiencia Renal en Espana (EPIRCE) pilot study, cross-sectional study, N = 237, response NR, aged ≥ 20 yrs. (mean age: 49.58 yrs.), 42.6% males. |
Overall: 5.1% |
NR |
|||
|
|
|
|
|
|
|||
| Verhave et al. [33] 2004 |
Netherlands |
Participants of the Prevention of Renal and Vascular End-stage Disease Study, cohort study, N = 6022, response NR, aged 28–75 yrs. (mean age: 48 yrs.), 51.5% males. |
NR |
Overall: 4.2% |
|||
|
|
|
|
|
|
|||
| Viktorsdottir et al. [34] 2005 |
Iceland |
Participants of the Reykijavik Heart Study, cross-sectional study. N = 19256, response NR, aged 33–85 yrs., 48% males. |
Overall: 7.2% Men: 3.7%, Women: 10.9% |
Overall: 24.7% Men: 19%, Women: 30% |
|||
| Age (yrs.) |
Men |
Women |
|||||
| 35–39 |
0.8% |
2.2% |
|||||
| 40–44 |
1.1% |
3.0% |
|||||
| 45–49 |
1.3% |
4.4% |
|||||
| 50–54 |
2.3% |
6.3% |
|||||
| 55–59 |
2.4% |
7.6% |
|||||
| 60–64 |
5.2% |
11.7% |
|||||
| 65–69 |
13.5% |
36.1% |
|||||
| 70–74 |
17.0% |
38.1% |
|||||
| 75–79 |
19.5% |
35.3% |
|||||
| 80+ |
24.5% |
53.1% |
|||||
|
|
|
|
|
|
|||
| Wasen et al. [35] 2004 |
Finland |
Participants from elderly residents in a community, cross-sectional study, N = 1246, response 83%, age 64–100 yrs. (mean age: 74 yrs.), 42% males. |
Overall: 35.8% |
Overall: 58.5% |
|||
|
MDRD: simplified equation of the Modification of Diet in Renal Disease Study. CG/BSA: Cockcroft-Gault formula adjusted by Body Surface Area. GFR: Glomerular Filtration Rate. NR: Not reported. | |||||||
Zhang and Rothenbacher BMC Public Health 2008 8:117 doi:10.1186/1471-2458-8-117 |
|||||||